Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(8%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_2
1
8%
Ph phase_3
5
42%
Ph not_applicable
1
8%
Ph phase_4
4
33%

Phase Distribution

1

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
5(41.7%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(11)

Detailed Status

Completed11
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 35 (41.7%)
Phase 44 (33.3%)
N/A1 (8.3%)

Trials by Status

completed1192%
recruiting18%

Recent Activity

1 active trials
Showing 5 of 12
recruitingphase_3

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

NCT04699604
completedphase_4

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

NCT00621959
completedphase_4

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

NCT00521131
completedphase_3

Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

NCT00544388
completedphase_3

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

NCT00524836
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT04699604Phase 3

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

Recruiting
NCT00621959Phase 4

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Completed
NCT00521131Phase 4

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Completed
NCT00544388Phase 3

Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

Completed
NCT00524836Phase 3

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

Completed
NCT00525278Phase 3

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Completed
NCT00521040Not Applicable

Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

Completed
NCT00542607Phase 4

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

Completed
NCT00520754Phase 2

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

Completed
NCT00525382Phase 3

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

Completed
NCT01567501Phase 1

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

Completed
NCT00653224Phase 4

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12